The team at Gide Loyrette Nouel A.A.R.P.I. is an industry heavyweight noted for handling a wide variety of work for its impressive client roster, which includes major players in biotech, life sciences, automotive, technology, and pharmaceutical industries. The firm is led by a trifecta of lawyers: Raphaëlle Dequiré-Portier, an expert at litigation in life sciences, technologies, and mechanics, Emmanuel Larere, a biotech, telecoms, and electronics specialist, and Jean-Hyacinthe de Mitry, who in addition to his contentious expertise advises on drafting and negotiating IP-related or technology transfer agreements. Marie-Ange Pozzo di Borgo is a stanchion for the firm and specialises in SPC matters, as well as CJEU and French Supreme Court work.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Very high quality work - great involvement in fully understanding the file.’
‘Raphaëlle Dequiré-Portier: great involvement in the files.'
‘Very strong team for French IP litigation - including oral and written advocacy. Particularly recommended for life sciences and pharma - including SPCs.’
‘Emanuel Larere and Raphaëlle Dequiré-Portier - superb advocates and leaders. Marie-Ange Pozzi di Borgo - provides excellent support, one to watch.'
- 'All are excellent at explaining (in English) the subtleties of the French system, and constructing the best arguments for the client.’
‘The team combines an in depth knowledge of the law and practice before the French IP courts, together with a creative streak that enables the team to propose creative approaches to navigate unprecedented legal situations. The team is able to work across the full scope of the life sciences.'
'The standard of the lawyers is high throughout the team and junior lawyers are given opportunities to practice their skills in court.’
‘Emmanuel Larere, aside from his unsurpassed experience before the French IP courts, is a very valued contributor as a member of an international team working on cross-border litigation. Emmanuel takes a broad view of both French litigation and how the case he is handling can contribute to the clients international strategy.’
Kernmandanten
- Meril Life Sciences
- Amgen
- Boeringher Ingelheim
- C.F.E.B. Sisley
- Thomson Licensing
- Vantiva
- Agri Advanced Technologies
- BMS
- Celltrion
- EDF
Highlight-Mandate
- Represented BMS in a revocation proceeding brought by Teva, a generic drug manufacturer, to invalidate a patent and the corresponding supplementary protection certificate, which covers the compound apixaban.
- Represented Meril Life Sciences as the defendant in a new pan-European patent litigation filed by Edwards Lifesciences, regarding 5 of its patents on prosthetic heart valves and delivery systems for the implantation of such heart valves.
- Representdd the French company Seratec in a patent entitlement claim action brought against a former partner, Orphalan.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
Raphaëlle Dequiré-Portier; Emmanuel Larere; Jean-Hyacinthe de Mitry
Weitere Kernanwält*innen
Marie-Ange Pozzi di Borgo